Also trades as: MOOD.CN (CNQ) · $vol 0M
DOSEF OTC
Doseology Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: -0.6%
YTD: -68.2%
1Y: -88.9%
3Y: -50.5%
$0.11
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.5M
52W Range0.0071-1
Volume5,000
Avg Volume263
Beta2.23
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher Jackson
Employees3
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2022-05-11
Websitedoseology.com
9-3151 Lakeshore Road
Kelowna, BC V1W 3S9
CA
Kelowna, BC V1W 3S9
CA
+1 236 547 7464
About Doseology Sciences Inc.
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders. Customers can acquire these items directly through its official e-commerce platform, doseology.com. Founded in 2019, Doseology Sciences Inc. is headquartered in Kelowna, Canada.
Latest News
Doseology Sciences names Kareem Baalbaki interim CEO, CFO
Doseology Announces Director and Officer Changes; Completes Shares-for-Debt Settlement
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors
Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format
Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors
Recent Insider Trades
No insider trades found